Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Industrial-scale genome sequencing
Crop Enhancement develop sustainable agrochemical formulations that employ environmentally friendly chemistry to improve crop yields.
IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.
Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients.
Mnemo Therapeutics specializes in biotechnology and life science.
Soteria is a biotechnology company that develops immunotherapies to treat cancer patients
SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies
Rheostat Therapeutics is a bio therapeutics company.
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Genetron Health is a world-leading expert in precision medicine.
Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases.
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
MouSensor is an early-stage biotech company.
System1 Biosciences is a neurotherapeutics company.
Nohla Therapeutics is a biotechnology company that develops a shelf alternative to bone marrow transplants.
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.
Alexandria Venture Investments has invested in 187 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 20 different industry categories.
Among tracked funding rounds, Skyhawk Therapeutics received $133.0M in a Series Unknown round. Alexandria Venture Investments's total known invested capital is $7.0B.
Alexandria Venture Investments's average investment size is $41.5M across its portfolio of 187 companies.
Recent Alexandria Venture Investments portfolio additions include Gencove, Crop Enhancement, IpiNovyx Bio, Skyhawk Therapeutics, Alphina Therapeutics. These companies were founded in 2020 or later.